Found: 11
Select item for more details and to access through your institution.
Brainstem gliomas in adults: prognostic factors and classification.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Meige's syndrome in a patient treated with ranitidine.
- Published in:
- 1999
- By:
- Publication type:
- journal article
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 6, p. 720, doi. 10.1177/1352458510396923
- By:
- Publication type:
- Article
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial.
- Published in:
- Drug Safety, 2021, v. 44, n. 2, p. 223, doi. 10.1007/s40264-020-01009-z
- By:
- Publication type:
- Article
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 7, p. 1637, doi. 10.1007/s00415-015-7758-8
- By:
- Publication type:
- Article
EFFECTS OF KETANSERIN ON CARDIOVASCULAR, SYMPATHO-ADRENAL AND ENDOCRINE SYSTEMS DURING PHYSICAL EXERCISE IN MAN.
- Published in:
- Fundamental & Clinical Pharmacology, 1987, v. 1, n. 2, p. 135, doi. 10.1111/j.1472-8206.1987.tb00552.x
- By:
- Publication type:
- Article
Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
- Published in:
- Multiple Sclerosis (13524585), 2009, v. 15, n. 9, p. 1085
- By:
- Publication type:
- Article
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.
- Published in:
- European Journal of Neurology, 2018, v. 25, n. 1, p. 120, doi. 10.1111/ene.13474
- By:
- Publication type:
- Article
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
- Published in:
- European Journal of Neurology, 2014, v. 21, n. 1, p. 40, doi. 10.1111/ene.12204
- By:
- Publication type:
- Article